Metastatic behavior of rhabdomyosarcoma

S. M. De La Monte, G. M. Hutchins, G. W. Moore

    Research output: Contribution to journalArticle


    Embryonal and alveolar rhabdomyosarcoma probably have the same histogenesis, yet alveolar rhabdomyosarcoma has a considerably worse prognosis and is generally less responsive to treatment. The metastatic behavior of rhabdomyosarcoma in 22 autopsied subjects was analyzed with respect to the histologic subtypes of the tumors to determine whether the more aggressive behavior of alveolar rhabdomyosarcoma was related to greater tumor burden and/or more widely disseminated metastases. Subjects with embryonal rhabdomyosarcoma tended to survive longer and had greater numbers of metastatic sites at autopsy compared to subjects with alveolar rhabdomyosarcoma, but these differences were not statistically significant. In addition, there were no significant differences in the overall distribution of metastases between embryonal and alveolar rhabdomyosarcoma. The most frequent sites of metastases from both types of tumor were soft tissues (73%), serosal surface (64%), lymph nodes (64%), lungs (55%), and bone marrow (50%). The findings suggest that the metastatic behavior of rhabdomyosarcoma does not vary as a function of length of survival, mode of therapy, or histologic subtype. The authors propose that factors such as stage of disease at presentation and location of the primary tumor, rather than histologic subtype, are probably the most important variables governing the therapeutic responsiveness of rhabdomyosarcoma.

    Original languageEnglish (US)
    Pages (from-to)148-152
    Number of pages5
    JournalPathology Research and Practice
    Issue number2
    StatePublished - 1986

    ASJC Scopus subject areas

    • Pathology and Forensic Medicine

    Fingerprint Dive into the research topics of 'Metastatic behavior of rhabdomyosarcoma'. Together they form a unique fingerprint.

  • Cite this

    De La Monte, S. M., Hutchins, G. M., & Moore, G. W. (1986). Metastatic behavior of rhabdomyosarcoma. Pathology Research and Practice, 181(2), 148-152.